Location: United States, Virginia, Manassas
Employees: 1-10
Total raised: $900K
Founded date: 2011
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.01.2024 | Grant | $900K | - |
Mentions in press and media 6
| Date | Title | Description |
| 15.02.2024 | Serpin Pharma Files U.S. Patent Application for SP16 - mRNA for Extended-Release in Injured Tissues | MANASSAS, VIRGINIA, UNITED STATES, February 15, 2024 /EINPresswire.com/ -- Serpin Pharma, a pioneering clinical-stage pharmaceutical company specializing in the treatment of inflammation, has announced the filing of a U.S. patent applicatio... |
| 01.02.2024 | Sanofi's $2.2B AAT Acquisition Highlights Need for New Treatments Like Serpin Pharma’s SP16, a AAT Bio superior | MANASSAS, VIRGINIA, UNITED STATES, February 1, 2024 /EINPresswire.com/ -- Sanofi’s recent acquisition of a recombinant alpha-1 antitrypsin (AAT) drug candidate for $2.2 billion highlights the critical need for innovative solutions in addres... |
| 26.01.2024 | Serpin Pharma Secures $900,000 BIRD Foundation Grant for Clinical Trial in AMI Treatment | MANASSAS, VIRGINIA, UNITED STATES, January 26, 2024 /EINPresswire.com/ -- Serpin Pharma, a pioneering clinical-stage pharmaceutical company headquartered in Virginia, has been awarded a competitive $900,000 grant by the Bi-national Industri... |
| 26.01.2024 | Sanofi's $2.2B ATT Acquisition Highlights Need for New Treatments Like Serpin Pharma’s SP16, a AAT Bio superior | MANASSAS, VIRGINIA, UNITED STATES, January 26, 2024 /EINPresswire.com/ -- Sanofi’s recent acquisition of a recombinant alpha-1 antitrypsin (AAT) drug candidate for $2.2 billion highlights the critical need for innovative solutions in addres... |
| 12.01.2024 | Serpin Pharma Welcomes Dr. Alexander Fleming to its Board of Directors | MANASSAS, VIRGINIA, UNITED STATES, January 12, 2024 /EINPresswire.com/ -- Serpin Pharma, a leading biopharmaceutical company dedicated to development anti-inflammatory and immune-modulating drugs to treat human diseases caused by inflammati... |
| 22.09.2022 | Serpin Pharma completes Phase 1b/2a SPIRIT Clinical Trial | MANASSAS, VIRGINIA, UNITED STATES, September 22, 2022 /EINPresswire.com/ -- Serpin Pharma, a clinical-stage biotech company developing first in class drugs to treat human diseases caused by inflammation, reported data from its Phase 1b/2a c... |